1. Alkem Laboratories
stock logo

34% Hold

Alkem Laboratories Share Price

ALKEM

₹6,194.15+₹34.85 (0.57%) TodayLast updated on 04 Oct, 2024 | 15:51 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹73,644 Crs

Open

₹6,175.00

Close

₹6,159.30

Circuit range

₹6,775.20 - ₹5,543.40

Day range

₹6,083.35 - ₹6,320.00

Year range

₹3,447.00 - ₹6,439.90

Volume

3,33,711

Avg. traded

₹6,255.69

Revenue (12m)

₹12,732 Crs

Alkem LaboratoriesAlkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.

Alkem Laboratories Key indicators

arrow

52 week high

₹6,439.90

52 week low

₹3,447.00

P/E ratio

35.85

P/B ratio

6.82

ROE

17.56%

ROCE

17.85%

Dividend yield

0.65%

Debt/Equity ratio

0.09

EPS

146.14

Learn more

Investment checklist: (5/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

33%

Hold

34%

Sell

33%

This analysis is based on the reviews of 18 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

22.11%

Net profit margin

17.01%

ROE

17.56%

ROA

14.32%

ROCE

17.85%

Learn more

Alkem Laboratories Shareholder returns

arrow

1 day

+0.13%

1 week

-1.08%

1 month

+0.83%

3 months

+23.91%

1 year

+72.36%

3 years

+54.37%

5 years

+224.46%

Alkem Laboratories Share Price history

arrow
DayOpenCloseDay’s change
Thu, Oct 3 2024
₹6,140.00
₹6,159.30
+0.13%
Tue, Oct 1 2024
₹6,099.00
₹6,151.25
+1.63%
Mon, Sep 30 2024
₹6,184.60
₹6,052.80
-2.13%
Fri, Sep 27 2024
₹6,197.15
₹6,184.60
-0.20%
Thu, Sep 26 2024
₹6,209.05
₹6,197.15
-0.47%
Wed, Sep 25 2024
₹6,075.00
₹6,226.65
+2.97%
Tue, Sep 24 2024
₹6,039.00
₹6,046.80
+1.08%
Mon, Sep 23 2024
₹6,111.00
₹5,982.45
-1.71%

Shareholding info

arrow

Promoters (56.38%)

Mutual Funds (14.72%)

Retail and other (16.36%)

Foreign institutions-FII (8.69%)

Other domestic institutions (3.85%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹35/share

    Ex date 16 Feb 2024

    expand tab
  • Dividend • ₹10/share

    Ex date 10 Aug 2023

    expand tab
  • Dividend • ₹25/share

    Ex date 17 Feb 2023

    expand tab
  • Dividend • ₹15/share

    Ex date 17 Feb 2023

    expand tab
  • Dividend • ₹4/share

    Ex date 08 Aug 2022

    expand tab
  • Dividend • ₹30/share

    Ex date 10 Feb 2022

    expand tab
  • Dividend • ₹5/share

    Ex date

    expand tab

Learn more

Frequently asked questions